Published April 22, 2026 | Version v1
Other Open

Is immunotherapy indicated in oropharyngeal squamous cell carcinoma that is p16+, HPV+, and PD-L1 with a high CPS score?

Authors/Creators

  • 1. Tripdatabase

Description

Immunotherapy is not currently recommended for HPV-positive oropharyngeal squamous cell carcinoma regardless of PD-L1 CPS score; standard treatment usually involves concurrent chemoradiation with cisplatin.

Files

9a6065f3-d572-4f57-9f3c-de25d920807f.pdf

Files (18.6 kB)

Name Size
md5:1c7b243ddab6f5d8ce81b6b22c70eef0
18.6 kB Preview Download

Additional details

Related works

Is identical to
https://www.tripdatabase.com/ask/is-immunotherapy-indicated-in-oropharyngeal-squamous-cell-carcinoma-p16-hpv-and-pd-l1-with-high-cps-score-9a6065f3-d572-4f57-9f3c-de25d920807f (URL)